STL Index for: Muna Shakhashiro

Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis

Discover icotrokinra, a groundbreaking oral peptide that targets the IL-23 receptor to treat moderate-to-severe plaque psoriasis. Clinical trials show it delivers biologic-like skin clearance in a convenient once-daily pill.

POPULAR